Investment Date
January 2020
Subsector
Outsourced Services
Website
fjb.pt/
Status
Current
Corporate HQ
Porto, Portugal

FairJourney Biologics is a leading biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma.

FairJourney Biologics combines its significant experience in phage display and proprietary mammalian display technology with a diverse approach to generating both immune and naïve antibodies to achieve a market-leading 99%+ project success rate.

GHO value creation

Enablement & Alignment

  • Supporting Management’s ambition to create a global leader in antibody discovery and engineering by working together with Management to build a combined forecast
  • Investing upfront and follow-on capital to facilitate new facility construction and M&A to support Management’s growth plans

Capability & Capacity

  • Investment in team and infrastructure to support platform for continued scaling (finance, operations, BD, manufacturing)
  • Organic and inorganic investment in new capabilities, technologies and capacity in order to capture growing share of market

Building Strategic Footprints

  • Extended footprint into UK with move into Cambridge, creating a pan-European platform
  • Active focus on transatlantic expansion via organic or inorganic move into North America to better support rapidly increasing transatlantic customer base

Better, faster + more accessible healthcare

IONTAS and FairJourney Biologics Discover SARS-CoV2 Neutralising Antibodies with Picomolar Potency

Subscribe to our email alerts

Email updates